INTELLIGENCE OVERVIEW
The U.S. FDA has issued guidance on Computer Software Assurance (CSA) for Production and Quality Systems, introducing a risk-based, critical-thinking approach to software validation in the pharmaceutical and medical device industries.
The guidance encourages companies to focus assurance efforts on patient safety, product quality, and data integrity, rather than excessive documentation.
INDUSTRY IMPACT
- Shifts validation from document-heavy CSV to risk-based assurance
- Enables faster adoption of digital tools and automation
- Reduces compliance burden while maintaining regulatory confidence
- Supports modern quality systems and digital transformation
Overall, FDA’s CSA guidance signals a move toward agile, efficient, and innovation-friendly compliance.
KEYWORDS: Quality Systems, Digital Quality, Software Validation
REFERENCE: https://www.fda.gov/media/188844/download